However, while the optimal cut-off and timing of specimen collection in different patient groups with AKI has yet to be established [14,15,23], at this stage the knowledge of a urinary NGAL does not appear to significantly improve the ability of the clinician to predict a requirement for RRT in this population. The gene discussed is LCN2; the disease is acute kidney injury.